The use of inductively coupled plasma mass spectrometry as a detector in drug metabolism studies

Bibliography

• Woolf TE, editor. Handbook of drug metabolism. Marcel Dekker, Inc.: New York; 1999
   Google Scholar
• Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman's: the pharmacological basis of therapeutics. 10th edition. McGraw-Hill Companies, Inc.: New York; 2001
   Google Scholar
• Rao RN, Talluri MVNK. An overview of recent applications of ICP-MS in determination of inorganic impurities in drugs and pharmaceuticals. J Pharm Biomed Anal 2007;43:1-13
   PubMed Web of Science ®Google Scholar
• Coomber DI, editor. Radiochemical methods in analysis. Plenum Press: New York; 1975
   Google Scholar
• White PC. Recent developments in detection techniques for HPLC Part II. Other detectors. Analyst 1984;109:973-84
   Web of Science ®Google Scholar
• Gray AL. Mass spectrometry with an ICP as an ion source: the influence on ultratrace analysis of background and matrix response. Spectrochim Acta B 1986;41B:151-67
   Google Scholar
• May TW, Wiedmeyer RH. A table of polyatomic interferences in ICP-MS. Atomic Spectroscopy 1998;19:150-5
   Web of Science ®Google Scholar
• Koppenaal D, Eiden GC, Barinaga CJ. Collision and reaction cells in atomic MS: development, status and applications. J Anal At Spectrom 2004;19:561-70
   Web of Science ®Google Scholar
• Huang J, Hu X, Li K, et al. The application of ICP-MS in pharmaceutical and biomedical analysis. J Pharm Biomed Anal 2006;40:227-34
   PubMed Web of Science ®Google Scholar
• Jakubowski N, Moens L, Vanhaecke F. Sector field mass spectrometers in ICP-MS. Spectrochim Acta B 1998;53:1739-63
   Web of Science ®Google Scholar
• Evans EH, Giglio JJ, Castillano TM, Caruso JA. Inductively coupled and microwave induced plasma sources for mass spectrometry. The Royal Society of Chemistry: Bodmin; 1995
   Google Scholar
• Tan SH, Horlick G. Matrix-effect observations in ICP-MS. J Anal At Spectrom 1987;2:745-63
   Web of Science ®Google Scholar
• Pan C, Zhu G, Browner RF. Comparison of desolvation effects with aqueous and organic (carbon tetrachloride) sample introduction for ICP-AES. J Anal At Spectrom 1990;5:537-42
   Web of Science ®Google Scholar
• Hu Z, Hu S, Gao S, et al. Volatile organic solvent-induced signal enhancements in ICP-MS: a case study of methanol and acetone. Spectrochim Acta B 2004;59B:1463-70
   Google Scholar
• Smith CJ, Wilson ID, Abou-Shakra F, et al. A comparison of the quantitative methods for the analysis of the platinum-containing anticancer drug cis-amminedichloro (2-methylpyridine))-platinum(II) by HPLC coupled to either a triple quadrupole MS or an ICP-MS. Anal Chem 2003;75:1463-9
   PubMed Web of Science ®Google Scholar
• Smith CJ, Wilson ID, Abou-Shakra F, et al. Analysis of a 14C-labelled platinum anticancer compound in dosing formulations and urine using a combination of HPLC-ICP-MS and flow scintillation counting. Chromatographia 2002;55:S151-5
   Web of Science ®Google Scholar
• Jensen BP, Smith C, Bailey C, et al. Application of ICP-MS and HPLC with parallel ESI-MS to the investigation of the deposition and matbolic fate of 2-, 3- and 4- iodobenzoic acids in rat. J Chromatogr B 2004;809:279-85
   PubMed Web of Science ®Google Scholar
• Jensen BP, Smith CJ, Bailey C, et al. Investigation of the metabolic fate of 2-, 3- and 4-bromobenzoic acid in bile-duct-cannulated rats by ICP-MS and HPLC-ICP-MS/ESI-MS. Rapid Commun Mass Spectrom 2005;19:519-24
   PubMed Web of Science ®Google Scholar
• Duckett CJ, Wilson ID, Walker H, et al. HPLC-ICP-MS with iodine specific detection for profiling the metabolites produced in the earthworm Eisenia veneta by exposure to 2-fluoro-4-iodoaniline. Rapid Commun Mass Spectrom 2003;17:1855-8
   PubMed Web of Science ®Google Scholar
• Corcoran O, Nicholson JK, Lenz EM, et al. Directly coupled LC with ICP-MS and orthogonal acceleration TOF-MS for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulphur detection. Rapid Commun Mass Spectrom 2000;14:2377-84
   PubMed Web of Science ®Google Scholar
• Abou-Shakra F, Sage AB, Castro-Perez J, et al. HPLC-UV diode array ICP-MS and oa-TOF-MS applied to simultaneous detection and identification of metabolites of 4-bromoaniline in rat urine. Chromatographia 2002;55:S9-13
   Web of Science ®Google Scholar
• Pereira AS, Schelfaut M, Lynen F, Sandra P. Design and evaluation of a multi-detection system composed of ultraviolet, evaporative light scattering and ICP-MS detection for the analysis of pharmaceuticals by liquid chromatography. J Chromatogr A 2008;1185:78-84
   PubMed Web of Science ®Google Scholar
• Cuyckens F, Balcaen LIL, De Wolf K, et al. Use of the bromine isotope ratio in HPLC-ICP-MS analysis of a new drug in development. Anal Bioanal Chem 2008;390:1717-29
   PubMed Web of Science ®Google Scholar
• Stefánka ZSKG, Stingeder G, Hann S. Down-scaling narrowbore LC-ICP-MS to capillary LC-ICP-MS: a comparative study of different introduction systems. J Anal At Spectrom 2006;21:86-9
   Web of Science ®Google Scholar
• Gammelgaard B, Jensen BJ. Application of inductively coupled plasma mass spectrometry in drug metabolism studies. J Anal At Spectrom 2007;22:235-49
   Web of Science ®Google Scholar
• Alvarez-Llamas G, Fernandez De LA Campa MDR, Sanz-Medel A. ICP-MS for specific detection in capillary electrophoresis. TrAC, Trends Anal Chem 2005;24:28-36
   Web of Science ®Google Scholar
• Prange A, Pröfrock D. Application of CE-ICP-MS and CE-ESI-MS in metalloproteomics: challenges, developments, and limitations. Anal Bioanal Chem 2005;383:372-89
   PubMed Web of Science ®Google Scholar
• Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK. Interactions of antitumour metallodrugs with serum proteins: advances in characterization using modern analytical methodology. Chem Rev 2006;106:2224-48
   PubMed Web of Science ®Google Scholar
• Timerbaev AR, Aleksenko SS, Polec-Pawlak K, et al. Platinum metallodrug-protein binding studies by CE-ICP-MS: characterization of interactions between Pt(II) complexes and human serum albumin. Electrophoresis 2004;25:1988-95
   PubMed Web of Science ®Google Scholar
• Polec-Pawlak K, Abramski JK, Semenova O, et al. Platinum group metallodrug-protein binding studies by capillary electrophoresis ICP-MS: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins. Electrophoresis 2006;27:1128-35
   PubMed Web of Science ®Google Scholar
• Timerbaev AR, Foteeva LS, Ruddnev AV, et al. Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CE. Electrophoresis 2007;28:2235-40
   PubMed Web of Science ®Google Scholar
• Montes-Bayon M, Pröfrock D, Sanz-Medel A, Prange A. Direct comparison of CE and capillary LC hyphenated to colision-cell ICP-MS for the investigation of Cd-, Cu- and Zn-containing metalloproteins. J Chromatogr A 2006;1114:138-44
   PubMed Web of Science ®Google Scholar
• Wilson ID, Nicholson JK, Castro-Perez J, et al. High resolution UPLC coupled to oa-TOF-MS as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteom Res 2005;4:591-8
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Scarfe G, et al. HPLC and ICP-MS for the analysis of xenobiotic metabolites in rat urine: application to metabolites of 4-bromoanailine. Analyst 2000;125:235-6
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Scarfe G, et al. HPLC linked to ICP-MS and orthogonal acceleration TOF-MS for the simultaneous detection and identification of metabolites of 2-bromo-4-trifluoromethyl-13C-acetanilide in rats. Anal Chem 2001;73:1491-4
   PubMed Web of Science ®Google Scholar
• Duckett CJ, Bailey NJC, Walker H, et al. Quantitation in gradient HPLC-ICP-MS investigated using diclofenac and chlorpromazine. Rapid Commun Mass Spectrom 2002;16:245-7
   PubMed Web of Science ®Google Scholar
• Duckett CJ, Lindon JC, Walker H, et al. Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICP-MS and HPLC-NMR. Xenobiotica 2006;36:59-77
   PubMed Web of Science ®Google Scholar
• Duckett CJ, Wilson ID, Douce DS, et al. Metabolism of 2-fluoro-4-iodoniline in earthworm Eisnia veneta using 19F-NMR spectroscopy, HPLC-MS and HPLC-ICP-MS. Xenobiotica 2007;37:1378-93
   PubMed Web of Science ®Google Scholar
• Cupid BC, Holmes E, Wilson ID, et al. Quantitative structure-metabolism relationships (QSMR) using computational chemistry: pattern recognition analysis and statistical prediction of Phase II conjugation reactions of substituted benzoic acis in rat. Xenobiotica 1999;29:27-42
   PubMed Web of Science ®Google Scholar
• Athersuch TJ, Duckett CJ, Castro-Perez J, et al. Metabolism of [14C]-5-chloro-1, 3-benzodioxol-4-amine in male Wistar-derived rats following intraperitoneal administration. Xenobiotica 2007;37:44-58
   PubMed Web of Science ®Google Scholar
• Iyengar GV. The elemental composition of Human tissues annd body fluids. Verlag Chemie; 1978
   Google Scholar
• Jensen BP, Gammelgaard B, Andersen JV, Hansen SH. HPLC-ICP-MS compared with radiochemical detection for metabolite profiling of 3-H bromohexine in rat urine and faeces. J Anal At Spectrom 2004;20:204-9
   Web of Science ®Google Scholar
• Balcaen LIL, Desamber B, De Wolf K, et al. Hyphenation of reverse-phase HPLC and ICP-MS for metabolite profiling - application to a novel antituberculosis compound as a case study. Anal Bioanal Chem 2007;389:777-86
   PubMed Web of Science ®Google Scholar
• Evans EH, Wollf J-C, Eckers C. Sulphur-specific detection of impurities in cimetidine drug substance using LC coupled to HR-ICP-MS and ESI-MS. Anal Chem 2001;73:4722-8
   PubMed Web of Science ®Google Scholar
• Wind M, Wesch H, Lehman WD. Protein phosphorylation degree: determination by capillary liquid chromatography and ICP-MS. Anal Chem 2001;73:3006-10
   PubMed Web of Science ®Google Scholar
• Pröfrock D, Leonhard P, Prange A. Determination of sulfur and selected trace elements in metallothionein-like proteins using CE hyphenated to ICP-MS with an octopole reaction cell. Anal Bioanal Chem 2003;377:132-39
   PubMed Web of Science ®Google Scholar
• Mason P, Kaspers K, Bergen MJ. Determination of sulphur isotope ratios and concentrations in water samples using ICP-MS incorporating hexapole ion optics. J Anal At Spectrom 1999;14:1067-74
   Web of Science ®Google Scholar
• Jensen BP, Smith C, Wilson ID, Weidolf L. Sensitive sulphur-specific detection of omeprazole metabolites in rat urine by HPLC-ICP-MS. Rapid Commun Mass Spectrom 2004;18:1-3
   PubMed Web of Science ®Google Scholar
• Stefanka Z, Hann S, Koellensperger G, Stingeder G. Investigations of the reaction of cisplatin with methionine in aqueous media using HPLC-ICP-DRC-MS. J Anal At Spectrom 2004;19:894-8
   Web of Science ®Google Scholar
• Sulyok M, Hann S, Hartinger CG, et al. Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(III) compound with plasma proteins. J Anal At Spectrom 2005;20:856-63
   Web of Science ®Google Scholar
• Hartinger CG, Hann S, Koellensperger G, et al. Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - significance for the patient. Int J Clin Pharm Ther 2005;43:583-5
   PubMedGoogle Scholar
• Hann S, Koellensperger G, Obinger C, et al. SEC-ICP-DRCMS and SEC-ICP-SFMS for determination of metal-sulphur ratios in metalloproteins. J Anal At Spectrom 2004;19:74-9
   Web of Science ®Google Scholar
• Fricker SP. Metal based drugs: from serendipity to design. Dalton Trans 2007;43:4903-17
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Z. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents. Dalton Trans 2008;12:1521-32
   PubMed Web of Science ®Google Scholar
• Bertini I, Gray HB, Stiefel EI, Valentine JS. Biological inorganic chemistry. University Science Books; 2007
   Google Scholar
• Zhao Z, Jones WB, Tepperman K, et al. Determination of gold based antiarthritis drugs and their metabolites in urine by reversed Phase Ion-pair chromatography with ICP-MS detection. J Pharm Biomed Anal 1992;10:279-82
   PubMed Web of Science ®Google Scholar
• Cepeda V, Fuertes MA, Castilla J, et al. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 2007;7:3-18
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Z. The role of sulfur in platinum anticancer chemotherapy. Anticancer Agents Med Chem 2007;7:19-34
   PubMed Web of Science ®Google Scholar
• Zhao Z, Tepperman K, Dorsey JG, Elder RC. Determination of cisplatin and some possible metabolites by ion-pairing chromatography with ICP-MS detection. J Chromatogr 1993;615:83-9
   PubMed Web of Science ®Google Scholar
• Heudi O, Cailleux A, Allain P. Kinetic studies of the reactivity between cisplatin and its monoaquo species with L-methionine. J Inorg Biochem 1998;71:61-9
   Web of Science ®Google Scholar
• Heudi O, Brisset H, Cailleux A, Allain P. Chemical instability and methods for measurement of cisplatin adducts formed by interactions with cysteine and glutathione. Int J Clin Pharmcol Ther 2001;39:344-9
   PubMed Web of Science ®Google Scholar
• Hann S, Zenker A, Galanski M, et al. HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate. Fresenius J Anal Chem 2001;370:581-6
   PubMedGoogle Scholar
• Allain P, Heudi O, Cailleux A, et al. Early biotransformations of oxaliplatin after its intravenous administration to cancer patients. Drug Metab Dispos 2000;28:1379-84
   PubMed Web of Science ®Google Scholar
• Mandal R, Kalke R, Li X. Mass spectrometric studies of cisplatin-induced changes of hemoglobin. Rapid Commun Mass Spectrom 2003;17:2748-54
   PubMed Web of Science ®Google Scholar
• Mandal R, Kalke R, Li X. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group. Chem Res Toxicol 2004;17:1391-7
   PubMed Web of Science ®Google Scholar
• Zhao Y, Mandal R, Li X. Intact human holo-transferrin interaction with oxaliplatin. Rapid Commun Mass Spectrom 2005;19:1956-62
   PubMed Web of Science ®Google Scholar
• Mandal R, Jiang G, Li X. Direct evidence for co-binding of cisplatin and cadmium to a native zink- and cadmium-containing metallothionein. Appl Organometal Chem 2003;17:675-81
   Web of Science ®Google Scholar
• Esteban-Fernández D, Cañas B, Pizarro I, et al. SEC-ICP-MS and ESI-MS as tools to study the interaction between cisplatin and cytosolic biomolecules. J Anal At Spectrom 2007;22:1121
   Google Scholar
• Esteban-Fernández D, Gómez-Gómez MM, Cañas B, et al.Speciation analysis of platinum antitumoral drugs in impacted tissues. Talanta 2007;72:773
   Google Scholar
• Xie R, Johnson W, Rodriguez L, et al. A study of the interactions between carboplatin and blood plasma proteins using size exclusion chromatography coupled to ICP-MS. Anal Bioanal Chem 2007;387:2822
   Google Scholar
• Khalaila I, Bergamo A, Bussy F, et al. The role of cisplatin and NAMI-A plasma protein interactions in relation to combination therapy. Int J Oncol 2006;29:261-8
   PubMed Web of Science ®Google Scholar
• Brouwers EEM, Tibben M, Rosing H, et al. The application of ICP-MS in clinical pharmacological oncology research. Mass Spectrom Rev 2008;27:67-100
   PubMed Web of Science ®Google Scholar
• Hann S, Koellensperger G, Stefanka Z, et al. Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine. J Anal At Spectrom 2003;18:1391-5
   Web of Science ®Google Scholar
• Bell DN, Liu JJ, Tingle MD, Mckeage MJ. Specific determination of intact cisplatin and monohydrated cisplatin in human plasma and culture medium ultrafiltrates using HPLC on-line with ICP-MS. J Chromatogr B 2006;837:34
   Google Scholar
• Galettis P, Carr JL, Paxton JW, Mckeage MJ. Quantitative determination of platinum complexes in human plasma generated from the oral antitumour drug JM216 using directly coupled HPLC-ICP-MS without desolvation. J Anal At Spectrom 1999;14:953-6
   Web of Science ®Google Scholar
• Vacchina V, Torti L, Allievi C, Lobinski R. Sensitive species-specific monitoring of a new triplatinum anti-cancer drug and its potential related compounds in spiked human plasma by cation-exchange HPLC-ICP-MS. J Anal At Spectrom 2003;18:884-90
   Web of Science ®Google Scholar
• Szpunar J, Makarov A, Pieper T, et al. Investigation of metallodrug-protein interactions by size-exclusion chromatography coupled with ICP-MS. Anal Chim Acta 1999;387:135-44
   Web of Science ®Google Scholar
• Miles DR, Mesfin M, Mody TD, et al. Validation and use of three complementary analytical methods (LC-FLS, LC-MS/MS and ICP-MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues. Anal Bioanal Chem 2006;385:345-56
   PubMed Web of Science ®Google Scholar
• Ciavardelli D, D'Anniballe G, Nano G, et al. An ICP-MS method for quantification of yttrium-antibody based drugs using stable isotope tracking. Rapid Commun Mass Spectrom 2007;21:2343-50
   PubMed Web of Science ®Google Scholar
• Sun H, Szeto KY. Binding of bismuth to serum proteins: implication of targets for Bi(III) in blood plasma. J Inorg Biochem 2003;94:114-20
   PubMed Web of Science ®Google Scholar
• Rodríguez-Farinas N, Gomez-Gomez MM, Camara-Rica C. Study of tungstate-protein interaction in human serum by LC-ICP-MS and MALDI-TOF. Anal Bioanal Chem 2008;390:29-35
   PubMed Web of Science ®Google Scholar
• Nagaoka MH, Akiyama H, Maitani T. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS. Analyst 2004;129:51-4
   PubMed Web of Science ®Google Scholar
• Fernandes KG, Montes-Bayon M, Gonzales EB, et al. Complementary FPLC-ICP-MS and MALDI-TOF for studying vanadium association to human serum proteins. J Anal At Spectrom 2005;20:210-5
   Web of Science ®Google Scholar
• Chéry CC, De Cremer K, Cornelis R, et al. Optimisation of ICP-DRC-MS as specific detector for the speciation analysis of vanadium at therapeutic levels in serum. J Anal At Spectrom 2003;18:1113-8
   Web of Science ®Google Scholar
• Miekeley N, Mortari SR, Schubach AO. Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biologcal samples from patients treated for leishmaniasis. Anal Bioanal Chem 2002;372:495-502
   PubMed Web of Science ®Google Scholar
• Slejkovec Z, Falnoga I, Goessler W, et al. Analytical artefacts in the speciation of arsenic in clinical samples. Anal Chim Acta 2008;607:83-91
   PubMed Web of Science ®Google Scholar
• Lawrence S. Biotech blockbusters consolidate market. Nat Biotechnol 2006;24:1466
   PubMed Web of Science ®Google Scholar
• Scheffer A, Engelhard C, Sperling M, Buscher W. ICP-MS as a new tool for the determination of gold nanoparticles in bioanalytical applications. Anal Bioanal Chem 2008;390:249-52
   PubMed Web of Science ®Google Scholar
• Sanz-Medel A. Heteroatom(isotope)-tagged proteomics via ICP-MS: screening and quantification of proteins and their post-translational modifications. Anal Bioanal Chem 2008;391:885-94
   PubMed Web of Science ®Google Scholar
• Evisa. European Virtual Institute for Speciation Analysis (EVISA) homepage. 2008. Available from: http://www.speciation.net/Public/Document/2007/06/21/2914.html
   Google Scholar
• Jensen BP, Gammelgaard B, Andersen JV, Hansen SH. HPLC-ICP-MS compared with radiochemical detection for metabolite profiling of 3-H bromohexine in rat urine and faeces. J Anal At Spectrom 2005;20:204-9
   Web of Science ®Google Scholar
• Jarvis KE, Gray AL, Houk RS. Handbook of inductively coupled plasma mass spectrometry. 1st edition. Blackie Academic &Professional: London; 1996
   Google Scholar
• Kwok K, Carr JE, Webster GK, Carnahan JW. Determination of active pharmaceutical ingredients by heteroatom selective detection using ICPMS with USN and membrane desolvation sample introduction. Appl Spectrosc 2006;60:80-5
   PubMed Web of Science ®Google Scholar
• Smith CJ, Wilson ID, Weidolf L, et al. Enhanced detection of sulphur and phosphorous containing compounds in HPLC-ICP-MS using chemical resolution via hexapole based reaction with oxygen. Chromatographia 2004;59:165-70
   Web of Science ®Google Scholar
• Wuilloud RG, Selar N, Kannamkumarath SS, Caruso JA. Determination of 2,4,6 triiodophenol and its metabolites in human urine by anion-exchange chromatography with ICP-MS detection. J Anal At Spectrom 2004;19:1442-7
   Web of Science ®Google Scholar
• Axelsson BO, Jörnten-Karlsson M, Michelsen P, Abou-Shakra F. The potential of ICP-MS detection for HPLC combined with accurate mass measurement of organic pharmaceutical compounds. Rapid Commun Mass Spectrom 2001;15:375-85
   PubMed Web of Science ®Google Scholar
• Kannamkumarath SS, Wuilloud RG, Stalcup A, et al. Determination of levothyroxine and its degradation products in pharmaceutical tablets by HPLC-UV-ICP-MS. J Anal At Spectrom 2004;19:107-13
   Web of Science ®Google Scholar
• Wind M, Eisenmenger A, Lehman WD. Modified DIHEN with minimized dead volume for the analysis of biological samples by micro- and nano-LC-ICP-MS. J Anal At Spectrom 2002;17:21-6
   Web of Science ®Google Scholar
• Takatera K, Watanabe T. Speciation of iodo amino acids by HPLC with ICP-MS detection. Anal Chem 1993;65:759-62
   Web of Science ®Google Scholar
• Cairns WRL, Ebdon L, Hill SJ. Development of an HPLC-ICP-MS method for the detemination of platinum species from new anti-tumour drugs. Anal Proc 1994;31:295-7
   Google Scholar
• Cairns WRL, Ebdon L, Hill SJ. A HPLC-ICP-MS interface employing desolvation for speciation studies of platinum in chemotherapy drugs. Fresenius J Anal Chem 1996;355:202-8
   Google Scholar
• Michalke B, Schramel P, Witte H. Iodine speciation in human serum by reversed phase LC-ICP-MS. Biol Trace Elem Res 2000;78:81-91
   PubMed Web of Science ®Google Scholar
• Michalke B, Schramel P, Witte H. Method developments for iodine speciation by RP-LC-ICP-MS. Biol Trace Elem Res 2000;78:67-79
   PubMed Web of Science ®Google Scholar
• Jensen BP, Gammelgaard B, Hansen SH, Andersen JV. Comparison of direct injection nebulizer and desolvating micro-concentric nebulizer for analysis of chlorine-, bromine- and iodine-containing compounds by reversed phase HPLC with ICP-MS detection. J Anal At Spectrom 2003;18:891-6
   Web of Science ®Google Scholar
• Marshall P, Heudi O, Mckeown S, et al. Study of bradykinin metabolism in human and rat plasma by LC with ICP-MS and oa-TOF-MS. Rapid Commun Mass Spectrom 2002;16:220-8
   PubMed Web of Science ®Google Scholar
• Ramírez-Molina C, Heudi O, Pullen M, Marshall PS. Study of bradykinin metabolism by rat lung tissue membranes and kidney brush border membranes by HPLC with ICP-MS and orthogonal acceleration TOF-MS. J Peptide Sci 2006;12:220-6
   PubMedGoogle Scholar
• Matz SG, Elder RC, Tepperman K. LC with an ICP-MS detector for simultaneous determination of gold drug metabolites and related metals in human blood. J Anal At Spectrom 1989;4:767-71
   Web of Science ®Google Scholar
• Elder RC, Zhao Z, Zhang Y, et al. Dicyanogold is a common human metabolite of different gold drugs. J Rheumatol 1993;20:268-72
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hess EV, Pryhuber KG, et al. Gold binding sites in red blood cells. Inorg Chim Acta 1995;229:271-80
   Web of Science ®Google Scholar
• Carr JL, Tingle MD, Mckeage MJ. Rapid biotransformation of satraplatin by human red blood cells in vitro. Cancer Chemother Pharmacol 2002;50:9-15
   PubMed Web of Science ®Google Scholar